Meaningful Results

michaelsdamoxygen.jpg

HGE Health is helping Providers and Payors drive results across their patient populations, while establishing standards of care for COPD management and clinical outcomes

80percentv3.png

Patient Engagement

More than 80% of patients consistently submit their COPD symptoms on a daily basis, seven days a week using HGE Health

6hrv4.png

Physician Engagement

Average Provider response time to Patients' symptom changes improved from 4+ days down to 6 hrs using HGE Health

50percent.png

lower utilization

HGE Health's Partners experience a considerable reduction of COPD patient-related Emergency Room visits, Inpatient admissions,  Inpatient days, and readmissions

Proven Outcomes

HGE Health ensures that Patient engagement links to outcomes

EJRT2R.jpg
 
 
sustainedengaged.png

Sustained Engagement

Daily compliance consistently exceeded 80% across patient populations


AECOPDOutcomes.png

Reduced Utilization

Annualized utilization outcomes by type of service both before and after enrollment in HGE Health


prepost.png

Utilization Avoidance

Achieved lower utilization than expected based on event rates, even for patients with no recent prior admissions

 
 

5 : 1 ROI

Engagement + Outcomes Results in Tangible ROI for HGE Health's Partners.  Typically, Providers and Payors begin to experience patient-level ROI within the first 120 days of launch

 
clouds.jpg
 

HGE Health Research

HGE Health continues to push forward to better understand and elevate the quality of care for people living with COPD


 
 

Published Articles

  1. Markers of Dental Health Correlate with Daily Respiratory Symptoms in COPD (Published Online, Journal of the COPD Foundation, Accepted November 8, 2017, Published as Original Research Volume 5 | Issue 2 | 2018)

  2. Use of a SmartPhone/Tablet-Based Bidirectional Telemedicine Disease Management Program Facilitates Early Detection and Treatment of COPD Exacerbation Symptoms (Published Online, Telemedicine and e-Health, Printed Online October 2015)

  3. A Telemedicine-Based Intervention Reduces the Frequency and Severity of COPD Exacerbation Symptoms: A Randomized Controlled Trial (Published Online, Telemedicine and e-Health, Printed Publication coming February 2016)

  4. Outcomes of COPD Exacerbations Treated with Corticosteroids, Antibiotics, or Both (Published Online, International Scholarly Research Network, Accepted July, 2011)

  5. The Effect of Chronic Sputum Production on Respiratory Symptoms in Severe COPD (Published Online, COPD: Journal of Chronic Obstructive Pulmonary Disease, Accepted August, 2011)

  6. Daily Peak Flow Expiratory Flow Rate and Disease Instability in Chronic Obstructive Pulmonary Disease (Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, Published November 2015)

 

HGE Health Related Clinical Trials (ClinicalTrials.gov)

btg.png

Evaluation of COPD Co-Pilot – BTG/PneumRx, Inc.  [ACTIVE, NOT RECRUITING]

btg.png

COPD Co-Pilot AIR Substudy of CLN0014 – BTG/PneumRx, Inc. [ENROLLING BY INVITATION]

btg.png

Evaluation of COPD Co-Pilot – BTG/PneumRx, Inc. [COMPLETED]

avisa.jpeg

Ability of an oral urease test to assess the oral microbiome in current and former smokers with COPD – AVISA Pharma, Inc.  [COMPLETED]

yung.jpeg

A Phase 2a Study to Assess Safety, Daily Symptoms, Pharmacokinetics (PK), and Biomarkers of YPL-001 in Chronic Obstructive Pulmonary Disease (COPD) Patients – Yungjin Pharma, Co.  [COMPLETED]

resmed.png

Respiration of Rate Monitoring in COPD Patients - ResMed  [COMPLETED]

 

MAY 2019 American thoracic Society (ATS) Meeting

HGE Health Abstracts:

  1. Session B44 - COPD: TREATMENT AND OTHER TOPICS, A3276 / P464 - A COPD Symptom Reporting Telemedicine System Reduces COPD and All Cause Healthcare Utilization, May 20, 2019, 11:15 AM - 1:00 PM (poster viewing time) - Area D (Hall F, Level 2), KBHCCD

  2. Session B44 - COPD: TREATMENT AND OTHER TOPICS, A3275 / P463 - Determining Eligibility of Patients for a Telemedicine Based Program Post COPD Hospitalization Discharge, May 20, 2019, 11:15 AM - 1:00 PM (poster viewing time) - Area D (Hall F, Level 2), KBHCCD

  3. Session C102 - COPD: RISK PREDICTION AND PROGNOSIS, A5649 / 219 - Chronic Bronchitis Is Associated with Longer COPD Exacerbations Compared to Those Without Chronic Bronchitis: An Analysis of the Temple Lung Center COPD Co-Pilot Telemedicine Program, May 21, 2019, 2:15 PM - 4:15 PM - Room C141/C143/C149 (Level 1), KBHCCD

  4. Session D102 - OPTIMIZING OUTCOMES IN COPD, A7117 / 216 - A Feasibility Study to Examine Real-World Use of Chronic Obstructive Pulmonary Disease (COPD) Daily Digital Respiratory Symptom Collection in a Primary Care Setting, Done in Partnership with AstraZeneca, May 22, 2019, 1:30 PM - 3:30 PM - Room C141/C143/C149 (Level 1), KBHCCD

 

Published American thoracic Society (ATS) Abstracts

(Sample of Select ATS Abstracts)

  1. Exacerbation Rates and Recovery Outcomes Following Glucocorticoid Treatment in Outpatients with Chronic Obstructive Pulmonary Disease

  2. Impact of Device Type and Patient Demographics on Compliance with a Telemedicine-Based Disease Management Program in COPD

  3. Impact of Nebulized Long-Acting Beta Agonists on Daily Symptoms of COPD Patients

  4. Greater Number of Teeth in COPD Patients with Poor Dental Health Correlates with Worse Daily Respiratory Symptoms

  5. Daily Respiratory Symptoms Based on Degree of Airflow Obstruction in Patients with COPD

  6. The Use of Oral Urease Activity as an Assessment of COPD Symptoms in Current and Former Smokers

  7. Patients with a COPD Emphysematous Phenotype Have Worse Daily Respiratory Symptoms

  8. Response Patterns of Respiratory Symptoms to Administration of Antibiotic Therapy in Outpatient Chronic Obstructive Pulmonary Disease Patients

  9. The Effect of AECOPD on Daily Peak Expiratory Flow

  10. Use of the Temple COPD phone Telemedicine Program in the Early Detection And Treatment of Acute COPD Exacerbations

  11. Evaluation of the COPD phone Telemedicine System in Daily COPD Symptom Reporting: PA-SCOPE

  12. Relationship of a COPD Daily Symptom Score to Quality of Life (QOL) and Functional Status

  13. Efficacy of Corticosteroids and Antibiotics in AECOPD

  14. Effect of a Telemedicine-Based Treatment Program for Acute COPD Exacerbation on Quality of Life: PA-SCOPE

  15. Use of Symptoms To Predict Treatment Failure in Acute Exacerbations of COPD

  16. COPD Patients Reveal Seasonal Trends in Daily Symptoms Using Electronic Reporting Tool

  17. Prevalence of Daily Respiratory Symptoms Reported by Electronic Diary Monitoring in COPD Patients: PA-SCOPE

  18. Evaluation of an Electronic Diary for Daily COPD Symptom Reporting: PA-SCOPE

  19. Participation in a Telemedicine Program for Chronic Obstructive Pulmonary Diseases Improves Daily Symptoms

  20. A Telemedicine-Based Disease Management Program for Daily COPD Symptom Reporting Reduces Hospitalizations, Hospital Length of Stay, and Emergency Room Visits

  21. Response of Respiratory Symptoms in Outpatient Chronic Obstructive Pulmonary Disease Patients to Administration of Prednisone Therapy

  22. Daily Peak Expiratory Flow Rate Measured at Home Reflects Laboratory Measurement of Peak Expiratory Flow Rate in Chronic Obstructive Pulmonary Disease (COPD)

  23. Effects of Age, Gender, Race, and Degree of Baseline Airflow Obstruction on Daily Peak Expiratory Flow Rate (PEFR) Variability in Moderate to Severe COPD

  24. Effects of BMI on COPD Exacerbation and Daily Symptoms

  25. Effect of Positive Airway Pressure (PAP) on the Daily Burden of COPD Respiratory Symptoms in Patients with COPD and OSA

  26. Daily Measurements of Nocturnal Respiratory Rate Variability May Predict COPD Exacerbations

  27. Flossing and Regular Dental Visits in Patients with COPD Is Associated with Fewer Days with Worse Respiratory Symptoms

  28. Combining Non-Contact Nocturnal Respiratory Monitoring with Respiratory Symptom Characterization to Enhance Early Detection of COPD Exacerbation

  29. Impact of Predictive Analytics to Identify Risk of Readmissions in COPD Patients for Better Management Post Discharge

  30. Impact of Mepolizumab on Daily Symptoms and Rate of Treated Exacerbations in Eosinophilic COPD

 
 

Want a partner to improve COPD care?

Join Us

 
dandelion.jpg